Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen’s Epogen, J&J’s Procrit Boost Heart Attack Patients’ Risk
Amgen’s Epogen, J&J’s Procrit Boost Heart Attack Patients’ Risk
Amgen’s Epogen, J&J’s Procrit Boost Heart Attack Patients’ Risk
Submitted by
admin
on May 11, 2011 - 8:47am
Source:
Bloomberg
News Tags:
Amgen
Epogen
JNJ
Procrit
anemia
Headline:
Amgen’s Epogen, J&J’s Procrit Boost Heart Attack Patients’ Risk
Do Not Allow Advertisers to Use My Personal information
